Phibro Animal Health | PAHC - Debt


Phibro Animal Health reported $474.17M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
Align Technology USD 121.27M 1.75M Sep/2025
ANI Pharmaceuticals USD 617.04M 3.28M Dec/2025
Assertio Holdings USD 38.87M 615K Sep/2023
Aurora Cannabis CAD 100.34M 1.29M Sep/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Canopy Growth CAD 259.33M 68.47M Sep/2025
Corcept Therapeutics USD 6.36M 247K Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Henry Schein USD 3.44B 83M Sep/2025
Idexx Laboratories USD 1.11B 124.31M Sep/2025
Knight Therapeutics CAD 106.24M 1.5M Sep/2025
Merck USD 41.37B 5.97B Sep/2025
Nektar Therapeutics USD 0 0 Jun/2022
Pacira USD 372.19M 4.53M Dec/2025
Phibro Animal Health USD 474.17M 730K Sep/2024
Prestige Brands USD 1.04B 1.7M Sep/2025
Supernus Pharmaceuticals USD 42.21M 10.44M Sep/2025
Zoetis USD 7.27B 482M Sep/2025